HAYA Therapeutics

HAYA Therapeutics is a precision medicine company developing RNA-guided programmable therapeutics targeting the "dark genome," the non-coding regions of the human genome, to reprogram disease-driving cell states. Their innovative platform focuses on long non-coding RNAs (lncRNAs) and their role in regulating gene expression and contributing to various diseases. HAYA's lead program is HTX-001, an antisense oligonucleotide targeting Wisper, a cardiac tissue-enriched driver of fibrosis in the heart, currently in preclinical development for the treatment of non-obstructive hypertrophic cardiomyopathy.

HAYA has a global presence, with headquarters in Lausanne, Switzerland, and laboratory facilities at JLABS @ San Diego. They are backed by a strong investor consortium and are actively expanding their pipeline of lncRNA-targeting precision therapies for a range of diseases including cardiovascular disease and cancer. The company is committed to identifying and developing breakthrough disease-modifying therapeutics that are more effective, safer, and more accessible than existing treatments.

HAYA Therapeutics emphasizes a collaborative team environment but does not explicitly mention remote work or flexible schedules in their job postings. All listed positions require a full-time presence on-site, suggesting that remote work is not offered, and flexibility may be limited.

HAYA Therapeutics is a precision medicine company focused on reprogramming disease-driving cell states by leveraging the power of the "dark genome." They develop RNA-guided therapeutics targeting long non-coding RNAs (lncRNAs) to address a range of diseases, including cardiovascular disease, metabolic conditions, and cancer. Their mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than currently available treatments.

HAYA Therapeutics promotes a culture of teamwork, innovation, and excellence. They value creativity and a positive 'can-do' attitude, encouraging employees to challenge existing norms and explore new approaches to problem-solving. They foster a collaborative work environment where communication and constructive feedback are encouraged. The company emphasizes adaptability and efficiency, recognizing the need to adjust to changing priorities and make quick decisions to achieve high-quality results. Integrity and critical thinking are also core values, emphasizing honesty, trust, and continuous learning.

HAYA Therapeutics emphasizes diversity, equity, and inclusion as core values, fostering a welcoming and collaborative work environment that values diverse perspectives and backgrounds. The company actively seeks to recruit and retain a diverse team of talented individuals with a passion for advancing precision therapeutics. HAYA also supports initiatives to promote equity and inclusion within the company and the broader scientific community.